Hypoxic pulmonary vasoconstriction: Physiology and anesthetic implications

Anesthesiology

Volumn 122, Issue 4, 2015, Pages 932-946

  Lumb, Andrew B ^a,b   Slinger, Peter ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALMITRINE; ANESTHETIC AGENT; CALCIUM ANTAGONIST; CARBON DIOXIDE; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; INDUCIBLE NITRIC OXIDE SYNTHASE; IRON; NITRIC OXIDE; NITRIC OXIDE DONOR; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN; STEROID; INHALATION ANESTHETIC AGENT;

ARTERIAL OXYGEN SATURATION; ATELECTASIS; BREATHING; CARBON DIOXIDE TENSION; CELL PH; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFECT; END TIDAL CARBON DIOXIDE TENSION; EPIDURAL ANESTHESIA; FETUS CIRCULATION; FUNCTIONAL RESIDUAL CAPACITY; GENERAL ANESTHESIA; HEART OUTPUT; HUMAN; HYPERCAPNIA; HYPOXEMIA; HYPOXIA; HYPOXIC LUNG VASOCONSTRICTION; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG BLOOD VESSEL; LUNG CIRCULATION; LUNG EDEMA; LUNG FUNCTION; LUNG PERFUSION; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; LUNG VENTILATION; LUNG VOLUME; NONHUMAN; ONE LUNG VENTILATION; OXYGEN CONSUMPTION; OXYGEN SENSING; OXYGENATION; PH; PRIORITY JOURNAL; PULMONARY ARTERY; REVIEW; ANIMAL; ANOXIA; DRUG EFFECTS; LUNG; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION; VASOCONSTRICTION;

ANESTHETICS, INHALATION; ANIMALS; ANOXIA; HUMANS; LUNG; PULMONARY CIRCULATION; VASOCONSTRICTION;

EID: 84932159575     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000569     Document Type: Review

References (109)

1. Beutner A: Ueber die Strom-und Druckkräfte des Blutes in der Arteria pulmonalis. Z rationelle Med 1852; 2:97-138
2. Haldane JS: Respiration. New Haven, Yale University Press, 1922, pp 427
3. Von Euler US, Liljestrand G: Observations on the pulmonary arterial blood pressure of the cat. Acta Physiol Scand 1946; 12:301-20
4. Sylvester JT, Shimoda LA, Aaronson PI, Ward JP: Hypoxic pulmonary vasoconstriction. Physiol Rev 2012; 92:367-520
5. Marshall BE, Marshall C, Frasch HF: Control of the pulmonary circulation, Anesthesia and the Lung. Edited by Stanley TH, Sperry RJ. Dordrecht, Kluwer, 1992, pp 9-18
6. Kapanci Y, Assimacopoulos A, Irle C, Zwahlen A, Gabbiani G: "Contractile interstitial cells" in pulmonary alveolar septa: A possible regulator of ventilation-perfusion ratio Ultrastructural, immunofluorescence, and in vitro studies. J Cell Biol 1974; 60:375-92
7. Talbot NP, Balanos GM, Dorrington KL, Robbins PA: Two temporal components within the human pulmonary vascular response to ~2 h of isocapnic hypoxia. J Appl Physiol 2005; 98:1125-39
8. Smith TG, Balanos GM, Croft QP, Talbot NP, Dorrington KL, Ratcliffe PJ, Robbins PA: The increase in pulmonary arterial pressure caused by hypoxia depends on iron status. J Physiol 2008; 586(Pt 24):5999-6005
9. Kiely DG, Cargill RI, Lipworth BJ: Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans. Chest 1996; 109:1215-21
10. Balanos GM, Talbot NP, Dorrington KL, Robbins PA: Human pulmonary vascular response to 4 h of hypercapnia and hypocapnia measured using Doppler echocardiography. J Appl Physiol (1985) 2003; 94:1543-51
11. Chuang IC, Dong HP, Yang RC, Wang TH, Tsai JH, Yang PH, Huang MS: Effect of carbon dioxide on pulmonary vascular tone at various pulmonary arterial pressure levels induced by endothelin-1. Lung 2010; 188:199-207
12. Loeppky JA, Scotto P, Riedel CE, Roach RC, Chick TW: Effects of acid-base status on acute hypoxic pulmonary vasoconstriction and gas exchange. J Appl Physiol (1985) 1992; 72:1787-97
13. Benumof JL, Wahrenbrock EA: Dependency of hypoxic pulmonary vasoconstriction on temperature. J Appl Physiol Respir Environ Exerc Physiol 1977; 42:56-8
14. Balanos GM, Dorrington KL, Robbins PA: Desferrioxamine elevates pulmonary vascular resistance in humans: Potential for involvement of HIF-1. J Appl Physiol (1985) 2002; 92:2501-7, pp 341-50
15. Smith TG, Talbot NP, Privat C, Rivera-Ch M, Nickol AH, Ratcliffe PJ, Dorrington KL, León-Velarde F, Robbins PA: Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: Two randomized controlled trials. JAMA 2009; 302:1444-50
16. Rhodes CJ, Wharton J, Howard L, Gibbs JS, Vonk-Noordegraaf A, Wilkins MR: Iron deficiency in pulmonary arterial hypertension: A potential therapeutic target. Eur Respir J 2011; 38:1453-60
17. Smith TG, Talbot NP, Dorrington KL, Robbins PA: Intravenous iron and pulmonary hypertension in intensive care. Intensive Care Med 2011; 37:1720
18. Hopkins SR, Levin DL: Heterogeneous pulmonary blood flow in response to hypoxia: A risk factor for high altitude pulmonary edema. Respir Physiol Neurobiol 2006; 151:217-28
19. Visscher MB: Normal and abnormal pulmonary circulation, Proceedings of the 5th Conference on Research in Emphysema. Edited by Grover RF. Aspen, Karger, 1962, pp 341-50
20. Hlastala MP, Lamm WJ, Karp A, Polissar NL, Starr IR, Glenny RW: Spatial distribution of hypoxic pulmonary vasoconstriction in the supine pig. J Appl Physiol (1985) 2004; 96:1589-99
21. Hopkins SR, Garg J, Bolar DS, Balouch J, Levin DL: Pulmonary blood flow heterogeneity during hypoxia and high-altitude pulmonary edema. Am J Respir Crit Care Med 2005; 171:83-7
22. Dehnert C, Risse F, Ley S, Kuder TA, Buhmann R, Puderbach M, Menold E, Mereles D, Kauczor HU, Bärtsch P, Fink C: Magnetic resonance imaging of uneven pulmonary perfusion in hypoxia in humans. Am J Respir Crit Care Med 2006; 174:1132-8
23. Schumacker PT: Lung cell hypoxia: Role of mitochondrial reactive oxygen species signaling in triggering responses. Proc Am Thorac Soc 2011; 8:477-84
24. Donnelly J, Cowan DC, Yeoman DJ, Lucas SJ, Herbison GP, Thomas KN, Ainslie PN, Taylor DR: Exhaled nitric oxide and pulmonary artery pressures during graded ascent to high altitude. Respir Physiol Neurobiol 2011; 177:213-7
25. Aaronson PI, Robertson TP, Ward JP: Endothelium-derived mediators and hypoxic pulmonary vasoconstriction. Respir Physiol Neurobiol 2002; 132:107-20
26. Dupuis J, Hoeper MM: Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 2008; 31:407-15
27. Pepke-Zaba J, Morrell NW: The endothelin system and its role in pulmonary arterial hypertension (PAH). Thorax 2005; 60:443-4
28. Cargill RI, Lipworth BJ: Acute effects of hypoxaemia and angiotensin II in the human pulmonary vascular bed. Pulm Pharmacol 1994; 7:305-10
29. Ghanayem NS, Gordon JB: Modulation of pulmonary vasomotor tone in the fetus and neonate. Respir Res 2001; 2:139-44
30. Ivy DD, le Cras TD, Parker TA, Zenge JP, Jakkula M, Markham NE, Kinsella JP, Abman SH: Developmental changes in endothelin expression and activity in the ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 2000; 278:L785-93
31. Dorrington KL, Balanos GM, Talbot NP, Robbins PA: Extent to which pulmonary vascular responses to PCO2 and PO2 play a functional role within the healthy human lung. J Appl Physiol (1985) 2010; 108:1084-96
32. Morrell NW, Nijran KS, Biggs T, Seed WA: Magnitude and time course of acute hypoxic pulmonary vasoconstriction in man. Respir Physiol 1995; 100:271-81
33. Domino KB, Wetstein L, Glasser SA, Lindgren L, Marshall C, Harken A, Marshall BE: Influence of mixed venous oxygen tension (PVO2) on blood flow to atelectatic lung. Anesthesiology 1983; 59:428-34
34. Rodriguez-Roisin R, Ballester E, Roca J, Torres A, Wagner PD: Mechanisms of hypoxemia in patients with status asthmaticus requiring mechanical ventilation. Am Rev Respir Dis 1989; 139:732-9
35. Kennedy TP, Michael JR, Huang CK, Kallman CH, Zahka K, Schlott W, Summer W: Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled double-blind study. Am Rev Respir Dis 1984; 129:544-51
36. Blanco I, Gimeno E, Munoz PA, Pizarro S, Gistau C, Rodriguez-Roisin R, Roca J, Barberà JA: Hemodynamic and gas exchange effects of sildenafil in patients with COPD and pulmonary hypertension. Am J Respir Crit Care Med 2010; 181:270-8
37. Kawashima A, Kubo K, Kobayashi T, Sekiguchi M: Hemodynamic responses to acute hypoxia, hypobaria, and exercise in subjects susceptible to high-altitude pulmonary edema. J Appl Physiol (1985) 1989; 67:1982-9
38. Smith TG, Talbot NP, Chang RW, Wilkinson E, Nickol AH, Newman DG, Robbins PA, Dorrington KL: Pulmonary artery pressure increases during commercial air travel in healthy passengers. Aviat Space Environ Med 2012; 83:673-6
39. Piercy V, Smith H, Arch JR: Effects of isoprenaline, adrenaline and selective 1-and 2-adrenoceptor stimulation on hypoxic pulmonary vasoconstriction in rat isolated perfused lungs. Pulm Pharmacol 1990; 3:59-63
40. Marin JL, Orchard C, Chakrabarti MK, Sykes MK: Depression of hypoxic pulmonary vasoconstriction in the dog by dopamine and isoprenaline. Br J Anaesth 1979; 51:303-12
41. McCormack DG, Barnes PJ, Evans TW: Effects of dopexamine hydrochloride on hypoxic pulmonary vasoconstriction in isolated rat lung. Crit Care Med 1990; 18:520-3
42. Lejeune P, Naeije R, Leeman M, Melot C, Deloof T, Delcroix M: Effects of dopamine and dobutamine on hyperoxic and hypoxic pulmonary vascular tone in dogs. Am Rev Respir Dis 1987; 136:29-35
43. Pillet O, Manier G, Castaing Y: Anticholinergic versus 2 agonist on gas exchange in COPD. Monaldi Arch Chest Dis 1998; 53:3-8
44. Papazian L, Roch A, Bregeon F, Thirion X, Gaillat F, Saux P, Fulachier V, Jammes Y, Auffray JP: Inhaled nitric oxide and vasoconstrictors in acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 160:473-9
45. Doering EB, Hanson CW III, Reily DJ, Marshall C, Marshall BE: Improvement in oxygenation by phenylephrine and nitric oxide in patients with adult respiratory distress syndrome. Anesthesiology 1997; 87:18-25
46. Schloss B, Martin D, Beebe A, Klamar J, Tobias JD: Phenylephrine to treat hypoxemia during one-lung ventilation in a pediatric patient. Thorac Cardiovasc Surg Rep 2013; 2:16-8
47. Thilenius OG, Candiolo BM, Beug JL: Effect of adrenergic blockade on hypoxia-induced pulmonary vasoconstriction in awake dogs. Am J Physiol 1967; 213:990-8
48. Lubbe N: The effect of clonidine on the intrapulmonary rightto-left shunt in one-lung ventilation in the dog. Anaesthetist 1991; 40:391-6
49. Brizzee BL, Walker BR: Chronic propranolol attenuates hypoxic pulmonary vasoconstriction in conscious rats. Respir Physiol 1989; 77:55-63
50. Shirai M, Shindo T, Ninomiya I: Adrenergic mechanisms attenuated hypoxic pulmonary vasoconstriction during systemic hypoxia in cats. Am J Physiol 1994; 266(5 Pt 2):H1777-85
51. Chen L, Miller FL, Clarke WR, Clergue FX, Marshall C, Marshall BE: Low-dose almitrine bismesylate enhances hypoxic pulmonary vasoconstriction in closed-chest dogs. Anesth Analg 1990; 71:475-83
52. Saadjian A, Philip-Joët F, Barret A, Levy S, Arnaud A: Nifedipine inhibits the effects of almitrine in patients suffering from pulmonary artery hypertension secondary to chronic obstructive pulmonary disease. J Cardiovasc Pharmacol 1993; 21:797-803
53. Moutafis M, Dalibon N, Liu N, Kuhlman G, Fischler M: The effects of almitrine on oxygenation and hemodynamics during one-lung ventilation. Anesth Analg 2002, 94:830-4
54. Dalibon N, Moutafis M, Liu N, Law-Koune JD, Monsel S, Fischler M: Treatment of hypoxemia during one-lung ventilation using intravenous almitrine. Anesth Analg 2004; 98:590-4
55. Gherardi R, Louarn F, Benvenuti C, Perrier M, Lejonc JL, Schaeffer A, Degos JD: Peripheral neuropathy in patients treated with almitrine dimesylate. Lancet 1985; 1:1247-50
56. Shimoda LA, Luke T, Sylvester JT, Shih HW, Jain A, Swenson ER: Inhibition of hypoxia-induced calcium responses in pulmonary arterial smooth muscle by acetazolamide is independent of carbonic anhydrase inhibition. Am J Physiol Lung Cell Mol Physiol 2007; 292:L1002-12
57. Basnyat B, Hargrove J, Holck PS, Srivastav S, Alekh K, Ghimire LV, Pandey K, Griffiths A, Shankar R, Kaul K, Paudyal A, Stasiuk D, Basnyat R, Davis C, Southard A, Robinson C, Shandley T, Johnson DW, Zafren K, Williams S, Weiss EA, Farrar JJ, Swenson ER: Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans. High Alt Med Biol 2008; 9:209-16
58. Schwarzkopf K, Klein U, Schreiber T, Preussetaler NP, Bloos F, Helfritsch H, Sauer F, Karzai W: Oxygenation during onelung ventilation: The effects of inhaled nitric oxide and increasing levels of inspired fraction of oxygen. Anesth Analg 2001; 92:842-7
59. Della Rocca G, Passariello M, Coccia C, Gabriella Costa M, Di Marco P, Venuta F, Rendina EA, Pietropaoli P: Inhaled nitric oxide administration during one-lung ventilation in patients undergoing thoracic surgery. J Cardiothorac Vasc Anesth 2001; 15:218-23
60. Leeman M, Lejeune P, Mélot C, Deloof T, Naeije R: Pulmonary artery pressure: Flow relationships in hyperoxic and in hypoxic dogs. Effects of methylprednisolone. Acta Anaesthesiol Scand 1988; 32:147-51
61. Fischler M, Maggiorini M, Dorschner L, Debrunner J, Bernheim A, Kiencke S, Mairbaürl H, Bloch KE, Naeije R, Brunner-La Rocca HP: Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema. Am J Respir Crit Care Med 2009; 180:346-52
62. Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G; Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group: Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005; 353:2148-57
63. Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM, Aldashev A, Wilkins MR: Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 2001; 104:424-8
64. D'Oliveira M, Sykes MK, Chakrabarti MK, Orchard C, Keslin J: Depression of hypoxic pulmonary vasoconstriction by sodium nitroprusside and nitroglycerine. Br J Anaesth 1981; 53:11-8
65. Hackett PH, Roach RC, Hartig GS, Greene ER, Levine BD: The effect of vasodilators on pulmonary hemodynamics in high altitude pulmonary edema: A comparison. Int J Sports Med 1992; 13(suppl 1):S68-71
66. Hales CA, Westphal D: Hypoxemia following the administration of sublingual nitroglycerin. Am J Med 1978; 65:911-8
67. Gomberg-Maitland M, Olschewski H: Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J 2008; 31:891-901
68. Lowson SM: Inhaled alternatives to nitric oxide. Anesthesiology 2002; 96:1504-13
69. Lennon PF, Murray PA: Attenuated hypoxic pulmonary vasoconstriction during isoflurane anesthesia is abolished by cyclooxygenase inhibition in chronically instrumented dogs. Anesthesiology 1996; 84:404-14
70. Leeman M, de Beyl VZ, Biarent D, Maggiorini M, Mélot C, Naeije R: Inhibition of cyclooxygenase and nitric oxide synthase in hypoxic vasoconstriction and oleic acid-induced lung injury. Am J Respir Crit Care Med 1999; 159(5 Pt 1):1383-90
71. Raghunathan K, Connelly NR, Robbins LD, Ganim R, Hochheiser G, DiCampli R: Inhaled epoprostenol during one-lung ventilation. Ann Thorac Surg 2010; 89:981-3
72. Kjaeve J, Bjertnaes LJ: Interaction of verapamil and halogenated inhalation anesthetics on hypoxic pulmonary vasoconstriction. Acta Anaesthesiol Scand 1989; 33:193-8
73. Kennedy T, Summer W: Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. Am J Cardiol 1982; 50:864-8
74. Burghuber OC: Nifedipine attenuates acute hypoxic pulmonary vasoconstriction in patients with chronic obstructive pulmonary disease. Respiration 1987; 52:86-93
75. Cargill RI, Lipworth BJ: Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans. Chest 1996; 109:424-9
76. Kiely DG, Cargill RI, Lipworth BJ: Acute hypoxic pulmonary vasoconstriction in man is attenuated by type I angiotensin II receptor blockade. Cardiovasc Res 1995; 30:875-80
77. Mancini GB, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM: Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 2006; 47:2554-60
78. Mortensen EM, Copeland LA, Pugh MJ, Restrepo MI, de Molina RM, Nakashima B, Anzueto A: Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir Res 2009; 10:45
79. Bjertnaes LJ: Hypoxia-induced pulmonary vasoconstriction in man: Inhibition due to diethyl ether and halothane anesthesia. Acta Anaesthesiol Scand 1978; 22:570-8
80. Marshall C, Lindgren L, Marshall BE: Effects of halothane, enflurane, and isoflurane on hypoxic pulmonary vasoconstriction in rat lungs in vitro. Anesthesiology 1984; 60:304-8
81. Benumof JL, Augustine SD, Gibbons JA: Halothane and isoflurane only slightly impair arterial oxygenation during one-lung ventilation in patients undergoing thoracotomy. Anesthesiology 1987; 67:910-5
82. Wang JY, Russell GN, Page RD, Jackson M, Pennefather SH: Comparison of the effects of sevoflurane and isoflurane on arterial oxygenation during one lung ventilation. Br J Anaesth 1998; 81:850-3
83. Pagel PS, Fu JL, Damask MC, Davis RF, Samuelson PN, Howie MB, Warltier DC: Desflurane and isoflurane produce similar alterations in systemic and pulmonary hemodynamics and arterial oxygenation in patients undergoing one-lung ventilation during thoracotomy. Anesth Analg 1998; 87:800-7
84. Van Keer L, Van Aken H, Vandermeersch E, Vermaut G, Lerut T: Propofol does not inhibit hypoxic pulmonary vasoconstriction in humans. J Clin Anesth 1989; 1:284-8
85. Reid C, Slinger P, Lenis S: A comparison of the effects of propofol-alfentanil versus isoflurane anesthesia during onelung ventilation. J Cardiothorac Vasc Anesth 1996; 10:860-3
86. Pruszkowski O, Dalibon N, Moutafis M, Jugan E, Law-Koune JD, Laloë PA, Fischler M: Effects of propofol vs sevoflurane on arterial oxygenation during one-lung ventilation. Br J Anaesth 2007; 98:539-44
87. Schulte-Sasse U, Hess W, Tarnow J: Pulmonary vascular responses to nitrous oxide in patients with normal and high pulmonary vascular resistance. Anesthesiology 1982; 57:9-13
88. Bindslev L, Cannon D, Sykes MK: Reversal of nitrous-oxide induced depression of hypoxic pulmonary vasoconstriction by lignocaine hydrochloride during collapse of the left lower lobe. Br J Anaesth 1986; 58:451-6
89. Gunnarsson L, Tokics L, Gustavsson H, Hedenstierna G: Influence of age on atelectasis formation and gas exchange impairment during general anaesthesia. Br J Anaesth 1991; 66:423-32
90. Karzai W, Schwarzkopf K: Hypoxemia during onelung ventilation: Prediction, prevention, and treatment. Anesthesiology 2009; 110:1402-11
91. Tarhan S, Lundborg DO: Carlens endobronchial catheter versus regular endotracheal tube during thoracic surgery. Can Anaesth Soc J 1971; 18:594-9
92. Benumof J: Isoflurane anesthesia and arterial oxygenation during one-lung anesthesia. Anesthesiology 1986, 64:419-22
93. Bjertnaes LJ, Hauge A, Torgrimsen T: The pulmonary vasoconstrictor response to hypoxia. The hypoxia-sensitive site studied with a volatile inhibitor. Acta Physiol Scand 1980; 109:447-62
94. Friedlander M, Sandler A, Kavanagh B, Winton T, Benumof J: Is hypoxic pulmonary vasoconstriction important during single lung ventilation in the lateral decubitus position. Can J Anaesth 1994; 41:26-30
95. Glasser SA, Domino KB, Lindgren L, Parcella P, Marshall C, Marshall BE: Pulmonary blood pressure and flow during atelectasis in the dog. Anesthesiology 1983; 58:225-31
96. Fukuoka N, Iida H, Akamatsu S, Nagase K, Iwata H, Dohi S: The association between the initial end-tidal carbon dioxide difference and the lowest arterial oxygen tension value obtained during one-lung anesthesia with propofol or sevoflurane. J Cardiothorac Vasc Anesth 2009; 23:775-9
97. Slinger PD, Kruger M, McRae K, Winton T: Relation of the static compliance curve and positive end-expiratory pressure to oxygenation during one-lung ventilation. Anesthesiology 2001; 95:1096-102
98. Dorrington KL, Clar C, Young JD, Jonas M, Tansley JG, Robbins PA: Time course of the human pulmonary vascular response to 8 hours of hypoxia. Am J Physiol 1997; 273:H1126-34
99. Kozian A, Schilling T, Fredén F, Maripuu E, Röcken C, Strang C, Hachenberg T, Hedenstierna G: One-lung ventilation induces hyperperfusion and alveolar damage in the ventilated lung: An experimental study. Br J Anaesth 2008; 100:549-59
100. Russell WJ, James MF: The effects of increasing cardiac output with adrenalin or isoprenaline on arterial oxygen saturation and shunt during one-lung ventilation. Anaesth Intens Care 2000; 28:636-41
101. Slinger P, Scott WA: Arterial oxygenation during one-lung ventilation. A comparison of enflurane and isoflurane. Anesthesiology 1995; 82:940-6
102. Wulff KE, Aulin I: The regional lung function in the lateral decubitus position during anesthesia and operation. Acta Anaesthesiol Scand 1972; 16:195-205
103. Watanabe S, Noguchi E, Yamada S, Hamada N, Kano T: Sequential changes of arterial oxygen tension in the supine position during one-lung ventilation. Anesth Analg 2000; 90:28-34
104. Garutti I, Quintana B, Olmedilla L, Cruz A, Barranco M, Garcia de Lucas E: Arterial oxygenation during one-lung ventilation: Combined versus general anesthesia. Anesth Analg 1999; 88:494-9
105. Ozcan PE, Sentürk M, Sungur Ulke Z, Toker A, Dilege S, Ozden E, Camci E: Effects of thoracic epidural anaesthesia on pulmonary venous admixture and oxygenation during onelung ventilation. Acta Anaesthesiol Scand 2007; 51:1117-22
106. Peinado VI, Santos S, Ramírez J, Roca J, Rodriguez-Roisin R, Barberà JA: Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: An in vitro study. Eur Respir J 2002; 20:332-8
107. Hanson CW III, Marshall BE, Frasch HF, Marshall C: Causes of hypercarbia with oxygen therapy in patients with chronic obstructive pulmonary disease. Crit Care Med 1996; 24:23-8
108. Simpson SQ: Oxygen-induced acute hypercapnia in chronic obstructive pulmonary disease: What's the problem. Crit Care Med 2002; 30:258-9
109. Carter EP, Sato K, Morio Y, McMurtry IF: Inhibition of KCa channels restores blunted hypoxic pulmonary vasocostriction in rats with cirrhosis. Am J Physiol 2000; 279:L903-L91